Clinical Trial Update: A Study to Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD. [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study in Japanese patients with chronic obstructive pulmonary disease assessing the tiotropium + olodaterol fixed-dose combination; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• olodaterol (olodaterol)
• tiotropium (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED | Results posted: 2015-07-15